Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients
Study Details
Study Description
Brief Summary
To compare the direct effect of sodium acetate ringer injection or albumin on volume expansion in shock patients, and to provide reference for volume resuscitation strategy in shock patients
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
CI/SVI increase amplitude and maintenance time
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: sodium acetate ringer
|
Drug: Compound sodium acetate ringer injection
Quickly infuse 500ml of compound sodium acetate ringer injection for volume expansion within 20-30 minutes
|
Active Comparator: albumin
|
Drug: Albumin
Quickly infuse 500ml of albumin for volume expansion within 20-30 minutes
|
Outcome Measures
Primary Outcome Measures
- Percentage of Cardiac output Index(CI) change [2 hour]
The changes of cardiac output index before and after volume expansion were compared
- Percentage of Stroke Volume Index(SVI)change [2 hour]
The changes of Stroke Volume Index before and after volume expansion were compared
Secondary Outcome Measures
- Duration of Cardiac output Index(CI) change [2 hour]
The duration of cardiac output index changes before and after volume expansion was compared
- Duration of Stroke Volume Index(SVI)change [2 hour]
The duration of Stroke Volume Index changes before and after volume expansion was compared
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age ≥ 18 years old, gender unlimited
-
Shock requires volume resuscitation:
Insufficient tissue perfusion: wet and cold skin, decreased urine volume (<0.5ml/kg/h), change of consciousness, blood lactate >2.0mmol/l or vasoactive drugs are required to maintain map>65mmhg
-
Presence of volume reactivity: (under controlled ventilation) PPV ≥ 15% or passive leg raising test (+) or (under controlled ventilation) IVC variability ≥ 18% or the presence of volume reactivity as judged by clinicians
-
The patient has no obvious restlessness, RASS ≤ 0
-
The legal representative of the subject signs the informed consent form-
Exclusion Criteria:
-
Pregnant and lactating women
-
End stage patients
-
BMI ≤ 15 or BMI ≥ 50
-
Contraindication of indwelling central vein catheter and invasive arterial catheter
-
Patients in ECMO and / or IABP therapy
-
Hemorrhagic shock, blood products such as concentrated red blood cells, plasma and platelets will be infused within 1 hour
-
Myocardial infarction, NYHA grade IV
-
Patients with hyperkalemia, hypercalcemia, hypermagnesemia and hypothyroidism
-
Allergic to compound sodium acetate ringer injection or albumin or with known side effects
-
Other factors that may affect the monitoring and evaluation of relevant indicators
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Peking Union Medical College Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PUMCH-ICU-LY